Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
2.800
+0.320 (12.90%)
Jan 22, 2025, 2:07 PM EST - Market open
Salarius Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 22, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 4 | 3 | 3 | 22 | 22 | 15 | |
| Market Cap Growth | -13.38% | -26.56% | -84.44% | 3.42% | 41.29% | - | |
| Enterprise Value | 1 | -5 | -13 | -9 | 13 | 12 | |
| Last Close Price | 2.48 | 5.20 | 12.24 | 99.12 | 182.00 | 756.00 | |
| PS Ratio | - | - | - | 12.17 | 4.14 | 4.42 | |
| PB Ratio | 1.22 | 0.48 | 0.34 | 0.58 | 0.98 | 1.45 | |
| P/TBV Ratio | 0.71 | 0.48 | 0.34 | 0.75 | 1.63 | 8.94 | |
| EV/Sales Ratio | - | - | - | - | 2.46 | 3.49 | |
| Debt / Equity Ratio | 0.11 | 0.05 | - | - | 0.02 | 0.05 | |
| Asset Turnover | - | - | - | 0.06 | 0.27 | 0.34 | |
| Quick Ratio | 3.51 | 4.54 | 3.22 | 13.84 | 5.40 | 1.13 | |
| Current Ratio | 4.09 | 5.02 | 3.40 | 14.29 | 5.70 | 1.42 | |
| Return on Equity (ROE) | -110.87% | -160.07% | -128.73% | -41.94% | -44.91% | -113.90% | |
| Return on Assets (ROA) | -53.17% | -75.90% | -51.76% | -24.35% | -25.07% | -50.38% | |
| Return on Capital (ROIC) | -66.56% | -100.98% | -58.48% | -26.10% | -28.86% | -81.47% | |
| Earnings Yield | -139.72% | -489.95% | -906.79% | -56.99% | -33.94% | -45.24% | |
| FCF Yield | -148.12% | -501.81% | -504.79% | -45.53% | -47.61% | -75.53% | |
| Buyback Yield / Dilution | -103.91% | -53.66% | -28.40% | -165.53% | -376.61% | - | |
| Total Shareholder Return | -103.91% | -53.66% | -28.40% | -165.53% | -376.61% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.